ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX03 | G | Methotrexate disodium - 15mg/0.3ml | 8064 | 140114/1 | METOJECT | 15mg/0.3ml | 1 x 0.3ml | Injectable solution | SC | Mersaco | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 1,968,729 L.L | 23.08 | B | Medac Gesellschaft Fur Klinische Spezialpraparate mbH | Germany | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AX03 | G | Methotrexate - 15mg/1.5ml | 5599 | 218030/09 | EBETREXAT | 15mg/1.5ml | 1 | Injectable solution | IV/IM/SC | Khalil Fattal & Fils S.A.L. | Fareva Unterach GmbH | Austria | 2,135,366 L.L | 23.08 | B | Ebewe Pharma GesmbH.NFG.KG | Austria | 12/12/20 | 0 |